bullish
Hygeia Healthcare Group (6078 HK) - Good Business Model with Large Market Potential
318 Views19 Jan 2021 09:41
This article analyzed Hygeia in terms of market potential for China oncology medical services and analysis on major types of business (the hospital business and the third-party radiotherapy business).
SUMMARY
(Sign Up to Access)Get started on the Smartkarma Research Network with a complimentary Preview Pass to:
- Unlock all research summaries
- Follow top, independent analysts
- Receive personalised alerts and emails
- Access Briefings, Analytics, and Events
Upgrade anytime to our paid plans for full-length research, real-time analyst discussions, and more.
Join a thriving community of 45,000+ investors, including the top global asset managers managing over $13trn in assets.
or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 5-minute read)
Discussions
(Paid Plans Only)
Top 5%
Xinyao (Criss) Wang
HK/China Healthcare Analyst (ex-Fosun Pharma)
- China Healthcare Weekly (Jan.22)25 Jan 2021
- Bloomage Biotechnology (688363.CH) - Accelerated Growth with the Approval of New Regulation21 Jan 2021
- Wuxi Biologics (2269 HK) - A Monopoly in China Macromolecule CDMO20 Jan 2021
- Hygeia Healthcare Group (6078 HK) - Good Business Model with Large Market Potential19 Jan 2021
- Presentation for Webinar: 2021 High Conviction-Investment Opportunities in China Healthcare Industry14 Jan 2021
- Chongqing Zhifei Biological Products- Promising Future After Successful Renewal of Contract with MSD14 Jan 2021
- Pre-IPO Basecare Medical - Here Are the the Strengths and Concerns23 Dec 2020
x